Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Study of Idebenone in Boys With Duchenne Muscular Dystrophy and Cardiac Dysfunction
2005-002520-33Phase 2Completed
- Sponsor
- Santhera Pharmaceuticals
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Duchenne muscular dystrophy (DMD) comparing Idebenone with Placebo (2 arms). Primary endpoint: Change in peak systolic radial strain of LV inferolateral wall. Started Oct 2005; status: completed.
02
Drugs
idebenone
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on 2005-002520-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002520-33.